Dos Santos AF et al., 2017-03-15: Breast cancer cell-line study in which methylene blue photodynamic therapy (20 uM, 640 nm, 4.5 J/cm2) massively killed MCF-7 and MDA-MB-231 breast cancer cells while non-malignant MCF-10A cells were significantly more resistant.
We observed that MB-PDT differentially induces massive cell death of tumour cells. Non-malignant cells were significantly more resistant to the therapy compared to malignant cells.
Dos Santos AF et al., 2017-03-15: Breast cancer cell-line study in which methylene blue photodynamic therapy (20 uM, 640 nm, 4.5 J/cm2) massively killed MCF-7 and MDA-MB-231 breast cancer cells while non-malignant MCF-10A cells were significantly more resistant. C3 dos Santos 2017. Study type: in vitro study, 2D monolayers and 3D basement-membrane cultures; lines MCF-10A (non-tumorigenic), MCF-7, MDA-MB-231. Country: Brazil. Dose: MB 20 uM; light 640 nm LED, 4.5 J/cm2. LIGHT REQUIRED: the design separates phototoxicity (light alone) and dark toxicity (MB alone) arms. Funder: FAPESP, CAPES, CNPq, NAP-PhotoTech-USP. Conflicts: none declared. Comparator: untreated, light-only, MB-only, and normal-like MCF-10A cells. The paper reports 'massive' death but gives no single percentage in the abstract; the viability curves are in Additional file 1. Also filed as MTG-011, MTG-025 (claims C2, C3, C4). Study type: lab.
